Arcutis Biotherapeutics, Inc.

NASDAQ:ARQT

8.72 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -262.14-311.458-206.356-135.678-41.996-19.255-4.978
Depreciation & Amortization 1.8810.9340.4540.1220.19500
Deferred Income Tax 19.81703.4540.114000
Stock Based Compensation 38.81332.68223.8927.9430.8240.1510.027
Change In Working Capital -23.501-10.1753.6214.133-1.5052.1080.279
Accounts Receivables -17.349-8.45800000
Inventory -5.62-7.51400000
Accounts Payables 3.1521.5650.2455.674-0.4581.2640.537
Other Working Capital -3.6844.2323.3758.459-1.0470.844-0.258
Other Non Cash Items -21.92730.3020.3090.333-0.3542.9110.897
Operating Cash Flow -247.057-257.715-174.627-113.033-42.836-14.085-3.775
Investing Activities:
Investments In Property Plant And Equipment -0.428-23.283-0.995-0.321-0.29500
Acquisitions Net -180.6622.9574.958181.50326.0300
Purchases Of Investments -225.84-415.389-292.508-279.103-60.83-11.5320
Sales Maturities Of Investments 406.5351.473217.5597.634.800
Other Investing Activites 180.66-22.95-74.958-181.503-26.03-11.5320
Investing Cash Flow 180.232-87.199-75.953-181.824-26.325-11.5320
Financing Activities:
Debt Repayment 0-122.813-72.35000-0.05
Common Stock Issued 101.323178.985209.597298.14594.23961.5937.069
Common Stock Repurchased 012.4680.8420.617000
Dividends Paid 0000000
Other Financing Activities 5.558-2.187-1.637298.145-1.13661.5937.119
Financing Cash Flow 101.323301.798281.947298.14593.10361.5937.119
Other Information:
Effect Of Forex Changes On Cash -0.05000000
Net Change In Cash 34.448-43.11631.3673.28823.94235.9763.344
Cash At End Of Period 89.32354.87597.99166.62463.33639.3943.418